Heterogeneity of δ-aminolevulinic acid-induced protoporphyrin IX fluorescence in human glioma cells and leukemic lymphocytes

Neurological Research

Volumn 22, Issue 4, 2000, Pages 361-368

  Eléouet, Sabine ^a   Rousset, Nathalie ^a   Carré, Jérôme ^a   Vonarx, Véronique ^a   Vilatte, Céline ^a   Louët, Cédric ^a   Lajat, Youenn ^a   Patrice, Thierry ^a  

^a CHU de Nantes   (France)

Author keywords

Glioma cells; Lymphocytes; Microspectro fluorometer; Photodynamic therapy; aminolevulinic acid

Indexed keywords

AMINOLEVULINIC ACID; PROTOPORPHYRIN;

AGED; ARTICLE; CLINICAL ARTICLE; CONFOCAL LASER MICROSCOPY; FEMALE; FLUORESCENCE; GLIOBLASTOMA; HUMAN; HUMAN CELL; LEUKEMIA; MALE; MICROFLUOROMETRY; TUMOR BIOPSY;

EID: 0343517459     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1080/01616412.2000.11740685     Document Type: Article

References (41)

1. Weishaupt KR, Gomer CJ, Dougherty TJ. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of murine tumors. Cancer Res 1976; 36: 2326-2329
2. Mitchell J, McPherson S, Degraff W, Camson J, Zabell A, Russo A. Oxygen dependence of hematoporphyrin derivative-induced photo-inactivation of Chinese hamster cells. Cancer Res 1985; 45: 2008-2011
3. Biel MA. Photodynamic therapy and the treatment of head and neck cancers. J Clin Laser Med Surg 1996; 14: 239-244
4. McCaughan JS. Photodynamic therapy of endobronchial and esophageal tumors: An overview, J Clin Laser Med Surg 1996; 14: 223-233
5. Kostron H, Obwegeser A, Jakober R. Photodynamic therapy in neurosurgery: A revíew. J Photochem Photobiol B: Biol 1996; 36: 157-168
6. Fink-Puches R, Hofer A, Smolle J, Kerl H, Wolf P. Primary clinical response and long-term follow-up of solar keratoses treated with topically applied 5-aminolevulinic acid and irradiation by different wavebands of light. J Photochem Photobiol B: Biol 1997; 41: 145-151
7. Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P. Grading of astrocytomas. A simple and reproducible method. Cancer 1988; 62: 2152-2165
8. Obwegeser A, Ortler M, Seiwald M, Ulmer H, Kostron H. Glioblastoma multiformae: An accumulated experience over 10 years. Acta Neurochir 1995; 137: 29-33
9. Perria C, Capuzzo T, Cavagnaro G, Datti R, Francaviglia N, Rivano C, Tercero VE. Fast attempts at the photodynamic treatment of human gliomas. J Neurosurg Sci 1980; 24: 119-129
10. Hill JS, Kaye AH, Sawyer WH, Morstyn G, Megison PD, Stylli SS. Selective uptake of hematoporphyrin derivative into human cerebral glioma. Neurosurgery 1990; 17: 248-254
11. Kaye AH, Hill JS. Photodynamic therapy of brain tumors. Ann Acad Med Singapore 1993; 22: 470-481
12. Hill JS, Kahl SB, Stylli SS, Nakamura Y, Koo MS, Kaye AH. Selective tumor kill of cerebral glioma by photodynamic therapy using boronated porphyrin photosensitizer. Proc Natl Acad Sci USA 1995; 92: 12126-12130
13. Wilson AC, Malham GM, Thomsen RJ, Harvey JD, Baguley BC. Determination of the activation spectrum of aluminium phthalocyanine chloride against cultured meningioma cells using a tunable laser. J Clin Neurosci 1996; 3: 252-256
14. Stummer W, Stocker S, Wagner S, Stepp H, Fritsch C, Goetz C, Goetz AE, Kiefmann R, Reulen HJ. Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. Neurosurgery 1998; 42: 518-526
15. Lilge L, Wilson BC. Photodynamic therapy of intracranial tissues: A preclinical comparative study of four different photosensitizers. J Clin Laser Med Surg 1998; 16: 81-91
16. Sieber F. Elimination of residual tumor cells from autologous bone marrow grafts by dye-mediated photolysis: Preclinical data. Photochem Photobiol 1987; 46: 71-76
17. Sieber F, Krueger GJ. Photodynamic therapy and bone marrow transplantation. Sem Hematol 1989; 26: 35-39
18. Atzpodien J, Gulati SC, Clarkson BD. Comparison of the cytotoxic effects of merocyanine-540 on leukemic cells and normal human bone marrow. Cancer Res 1986; 46: 4892-4895
19. Edelson R. Treatment of cutaneous T-cell lymphoma by extra-corporal photochemotherapy. Preliminary results. New Engl J Med 1987; 316: 297-303
20. Jamieson CHM, McDonald WN, Levy JG. Preferential uptake of benzoporphyrin derivative by leukemic versus normal cells. Leukemia Res 1990; 14: 209-219
21. Jamieson C, Hornby A, Richter A, Mitchell D, Levy J. Relative sensitivity of leukemic (CML) and normal progenitor cells to treatment with the photosensitizer benzoporphyrin derivative and light. J Hematother 1993; 2: 383-386
22. Malik Z, Lugaci H. Selective destruction of erythroleukemic cells by photo-activation of endogenous porphyrins. Br J Cancer 1987; 56: 589-595
23. Malik Z, Ehrenberg B, Faraggi A. Inactivation of erythrocytic, lymphocytic and myelocytic leukemic cells by photoexcitation of endogenous porphyrins. J Photochem Photobiol B: Biol 1989; 4: 195-205
24. Kennedy JC, Pettier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: Basic principles and present clinical experience. J Photochem Photobiol B: Biol 1990; 6: 143-148
25. Cairnduff F, Stringer MR, Hudson EJ, Ash DV, Brown SB. Superficial photodynamic therapy with topical 5-aminolevulinic acid for superficial primary and secondary skin cancer. Br J Cancer 1994; 69: 605-608
26. Svanberg K, Andersson T, Killander D, Wang I, Stenram U, Andersson-Engels S, Berg R, Johansson J, Svanberg S. Photodynamic therapy of non-melanoma malignant tumours of the skin using topical δ-aminolevulinic acid sensitization and laser irradiation. Br J Dermatol 1994; 130: 743-751
27. Calzavara-Pinton PG. Repetitive photodynamic therapy with topical δ-aminolevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours. J Photochem Photobiol B: Biol 1995; 29: 53-57
28. Waidelich R, Hofstetter A, Stepp H, Baumgartner R, Weninger E, Kriegmair M. Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of upper tract urothelial tumors. J Urol 1998; 159: 401-404
29. Gossner L, Stolte M, Sroka R, Rick K, May A, Hahn EG, Ell C. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid [see comments]. Gastroenterology 1998; 114: 448-455
30. Fritsch C, Abels C, Coetz AED, Stahl W, Bolsen K, Ruzicka T, Goerz G, Sies H. Porphyrins preferentially accumulate in a melanoma following intravenous injection of 5-aminolevulinic acid. Biol Chem 1997; 378: 51-57
31. Hornung R, Major AL, McHale M, Liaw LHL, Sabiniano LA, Tromberg BJ, Berns MW, Tadir Y. In vivo detection of metastatic ovarian cancer by means of 5-aminolevulinic acid-induced fluorescence in a rat model. J Am Assoc Gynecol Laparosc 1998; 5: 141-148
32. Xiao Z, Miller CG, McCallum TJ, Brown KM, Lown JW, Tulip J, Moore RB. Biodistribution of Photofrin II and 5-aminolevulinic acid-induced protoporphyrin IX in normal rat bladder and bladder tumor models; implications for photodynamic therapy. Photochem Photobiol 1998; 67: 573-583
33. Johansson J, Berg R, Svanberg K, Svanberg S. Laser-induced fluorescence studies of normal and malignant tumour tissue of rat following intravenous injection of delta-amino levulinic acid. Lasers Surg Med 1997; 20: 272-279
34. Becker DM, Kramer S. The neurological manifestations of porphyria: A review. Medicine 1977; 56: 411-419
35. Wyld L, Reed MWR, Brown NJ. The influence of hypoxia and pH on aminolevulinic acid-induced photodynamic therapy in bladder cancer cells in vitro. Br J Cancer 1998; 77: 1621-1627
36. Bech O, Phillips D, Moan J, MacRobert AJ. A hydroxypyridinone (CP94) enhances protoporphyrin IX formation in 5-aminolevulinic acid treated cells. J Photochem Photobiol B: Biol 1997; 41: 136-144
37. Berg K, Anholt H, Bech O, Moan J. The influence of iron chelators on the accumulation of protoporphyrin IX in 5-aminolevulinic acid-treated cells. Br J Cancer 1996; 74: 688-697
38. Moan J, Bech O, Gaullier JM, Stokke T, Steen HB, Ma LW, Berg K. Protoporphyrin IX accumulation in cells treated with 5-aminolevulinic acid: Dependence on cell density, cell size and cell cycle. Int J Cancer 1998; 75: 134-139
39. Schoenfeld N, Epstein O, Lahav M, Mamet R, Shaklai M, Atsmon A. The heme biosynthetic pathway in lymphocytes of patients with lymphoproliferative disorders. Cancer Lett 1988; 43: 43-48
40. Hua Z, Gibson SL, Foster TH, Hilf R. Effectiveness of δ-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo. Cancer Res 1995; 55: 1723-1731
41. Roy BN, Van Vugt DA, Weagle GE, Pottier RH, Reid RL. Effect of continuous and multiple doses of 5-aminolevulinic acid on protoporphyrin IX concentrations in the rat uterus. J Photochem Photobiol B: Biol 1997; 41: 122-127